IL10 and neoplasm: While polysaccharides can enhance anti-tumor immunity through immune activation [51,52,53], the TME harbors immunosuppressive elements—including regulatory T cells (Tregs), MDSCs, TAMs, and cytokines like TGF-β and IL-10 [54,55]—that inhibit immune cell activity and compromise immunotherapy efficacy.